Showing posts with label #tweet. Show all posts
Showing posts with label #tweet. Show all posts

Wednesday, May 25, 2016

Have you heard about our Meet The Yankees and Mets event?!

$265.00 per person includes dinner, drinks, meet & greet 

SPONSORED BY: 
National Waste Services
The Sanders Firm
BluChip Marketing
The Alpert Group Of Wells Fargo Advisors, LLC CAR-0516-0230
Giorgenti Men's Custom Suits
Cloud 9 Exotics
The Fox Hollow & Scotto Family

Wednesday, March 30, 2016

Smoking and TB - A Dangerous Duo

A Message From Senior Attorney Robert Jackson 
We have come a long way from the days of Doctors smoking Cigarettes, claiming health benefits. As we know, smoking is detrimental to health, leading to diseases from Asthma to Cancer.

Smoking puts people at higher risk of developing tuberculosis.
Tuberculosis is caused by an infectious bacteria. It leads to lung problems and, in some cases, death.
The disease first attacks immune cells called macrophages in the body. Often, the macrophages win that battle and are able to ward off infection. But in people who smoke, smoke particles clog up these immune cells. The macrophages become full of toxins from cigarettes and aren't able to move as quickly as needed. That makes the bacteria more likely to evade the body's defenses.
Tuberculosis has become a cause for concern among the general population. The Centers for Disease Control have found that the number of cases in the US rose last year for the first time in nearly 25 years.

Protect yourself and loved ones from falling victim to this disease. 

Call 1.800.FAIR.PLAY for more information. The Sanders Firm cares.

Monday, March 28, 2016

Allegations Chemo Drug Taxotere Causes Permanent Hair Loss

chemotherapy drugThe chemotherapy drug Taxotere has been touted as a powerful cancer fighter for many years, helping those with some types of cancer find effective treatment for their illness.
However, one of the potential side effects related to Taxotere, permanent hair loss, has not been widely publicized by the drug’s manufacturer, Sanofi. Patients who have not been warned about this potential side effect may be diagnosed with permanent alopecia after their cancer treatments.
Now, some of those patients are considering legal action against Sanofi, claiming lack of adequate warnings left them at a distinct disadvantage when choosing their cancer treatment.

What is Taxotere?

Taxotere is a chemotherapy drug prescribed to treat some types of breast, lung, stomach, prostate, and head and neck cancers. It is also currently under investigation for the treatment of additional cancers, including ovarian, bladder and pancreatic cancers. The drug is given intravenously and dosing depends on the type of cancer and the patient’s height, weight and overall health.

Taxotere and hair loss

Taxotere is linked to numerous side effects common with other chemotherapy medications, including nausea, diarrhea, fatigue, weakness, and hair loss. However, while temporary hair loss is a common byproduct of some chemotherapy treatments, permanent hair loss is not typical. In fact, Taxotere is the only medication at this time that has been linked to reports of permanent hair loss among some cancer patients.

No warning of permanent alopecia

To date, the warning label for Taxotere in the US has not indicated the drug could cause permanent alopecia or hair loss. This has left some chemotherapy patients vulnerable to permanent disfigurement without knowledge that they were putting themselves at risk. Even more troubling is the fact that other chemotherapy medications that are just as effective as Taxotere are not linked to permanent hair loss.
Despite the lack of a proper warning, studies have indicated permanent alopecia may be a risk with Taxotere for some time. According to a recent product liability lawsuit filed in U.S. District Court in California, a 2005 study known as the GEICAM 9805 demonstrated that nearly 10 percent of the test patients that took Taxotere in this study suffered persistent alopecia that lasted at least 10 years and five months. In 2006, a Colorado oncologist noted that more than six percent of the patients he treated with Taxotere continued to suffer with hair loss for many years after their treatments.
In December 2015, the FDA acknowledged there have been reports of permanent hair loss in some patients using Taxotere. That announcement by the FDA preceded a label change for the product, noting the possibility of permanent hair loss.

Seeking legal action

Now, individuals like the plaintiff in California are filing lawsuits against Sanofi, alleging the company did not provide adequate warnings about alopecia risks. Those plaintiffs are seeking damages for their permanent disfigurement, asserting that if they had known about this risk with Taxotere, they would have chosen a different chemo drug.
The plaintiff in California is seeking damages in excess of $75,000, which necessitated the lawsuit filing in federal court. This plaintiff, like others now pending in courts across the country, states in her complaint that Taxotere use left her with “severe and permanent injuries that are lasting in nature.”
Product liability lawyers at The Sanders Firm are are currently reviewing cases involving Taxotere hair loss. For a free evaluation of your case, contact our offices today at 1-800-FAIR-PLAY.